Swimming while on chemotherapy and radiotherapy—a lifesaver!
Meet Derek Yach, MBBS, MBChB, MPH. Dr. Yach writes of his lifelong love of swimming, and how after his cancer diagnosis he grappled with the news of potentially never being able to swim again. However, with guidance from his care team, he was able to continue his passion – and reap the mental and physical benefits of resuming exercise.
Six Smilow Radiation Oncology centers receive accreditation by the American Society for Radiation Oncology (ASTRO)
Smilow Cancer Hospital at Yale New Haven announced that its six Radiation Oncology centers have all been accredited by the American Society for Radiation Oncology (ASTRO) through its APEx-Accreditation Program for Excellence; five are reaccreditations.
Advances in Particle Therapy - Proton Track-end Counts and Helium Ion Treatment Planning
Editor-in-Chief Dr. Sue Yom and Physics Section and Executive Editor Dr. David Carlson, Professor, Vice Chair, and Director of Medical Physics at Yale University, host a discussion of current research frontiers in particle therapy. Our guests (calling in from PTCOG!) are Dr. Tracy Underwood, Senior Physicist at Leo Cancer Care and one of the supervising authors of Proposing a Clinical Model for RBE Based on Proton Track-End Counts, and Dr. Andrea Mairani, Group Leader of Biophysics at Heidelberg Ion Beam Therapy Center and supervising author of Commissioning of Helium Ion Therapy and the First Patient Treatment With Active Beam Delivery.Source: Red Journal Podcasts
Impact of Changing Landscape for Patients With Cancer Who Are Prescribed Opioids
In response to the opioid epidemic in the United States, interventions to prevent over-prescribing and misuse of opioids were enacted at institutional, state, and federal levels. To assess how changes in the prescribing landscape affected patients, a research team from the Yale COPPER Center examined the rates of both new and persistent opioid prescribing in patients with cancer as well as in patients without cancer, utilizing data from SEER-Medicare.
Dr. Park on the Role of Radiation Therapy in NSCLC
Henry S. Park, MD, MPH, discusses the importance of considering radiation therapy in patients with non–small cell lung cancer and how this therapeutic approach can work in concert with targeted therapy and other systemic therapies.Source: OncLive
Blavatnik Fund for Innovation at Yale Awards $2.5 Million to 11 Faculty-Led Projects
The Blavatnik Fund for Innovation at Yale, made possible by a generous grant from the Blavatnik Family Foundation, supports Yale faculty in the commercialization of biomedical and digital health innovations.Source: Yale Ventures
Yale Cancer Center and Smilow Cancer Hospital Physicians and Scientists Presenting Latest Advances at 2023 ASCO Annual Meeting
Yale Cancer Center and Smilow Cancer Hospital scientists and clinicians will present new research at the 2023 Annual Meeting of the American Society of Clinical Oncology (ASCO), June 2nd to June 6th at McCormick Place in Chicago, Illinois. This year’s scientific program will feature more than 2,900 abstracts, covering all major diseases and research areas, including breast, lung, head and neck, gynecological, prostate, and gastric cancers.
Gastrointestinal Cancers Specialty Team Smilow Cancer Hospital at Trumbull
The Gastrointestinal Cancers Specialty Team at Smilow Cancer Hospital in Trumbull brings together a team of clinicians whose focus is to care for patients with cancers of the esophagus, stomach, liver, pancreas, colon, bile ducts, rectum, and anus.
Connecticut Magazine’s 2023 “Top Doctors” issue recognizes 81 Smilow Cancer Hospital and Yale Cancer Center physicians
Each year, Connecticut Magazine recognizes some of the state’s best physicians, who provide exceptional care for patients, with its annual “Top Doctors” issue. This year’s list includes 82 physicians from Smilow Cancer Hospital and Yale Cancer Center, the only National Cancer Institute-designated comprehensive cancer center in the state.
Yale researchers to present new data on novel treatment for drug-resistant brain cancers at AACR Meeting
A research team led by Yale Cancer Center members Seth Herzon, PhD, and Ranjit Bindra, MD, PhD, developed new molecules that exploit a specific DNA-repair defect in these brain cancers to achieve tumor-specific cell killing.
Yale Cancer Center Experts to Present New Research at Annual AACR Meeting
Yale Cancer Center and Smilow Cancer Hospital physicians and scientists are presenting research studies at the 2023 American Association for Cancer Research (AACR) Annual Meeting at the Orange County Convention Center in Orlando, Florida, April 14 to 19. Research teams will reveal the latest data on treatments and diagnostic advances as well as new findings on head and neck, lung, and metastatic cancers.